The Cochrane database of systematic reviews. 12: CD006921. These tests are also used to rule out other conditions. Accessed Dec. 16, 2014. the available evidence substantiates neither clinically significant benefit nor harm from vitamin D in the treatment of patients with MS ^ Chong MS, Wolff K, Wise K, Tanton C, Winstock A,
doi:10.1007/s100720100044. Clinical Pharmacology & Therapeutics. 2014;95:32. Epidemiology and clinical features of multiple sclerosis in adults. doi:10.1016/S1474-4422(05)01017-3. http://www.nationalmssociety.org/What-is-MS
Chronic fatigue occurs when nerves deteriorate in the spinal column. Make an appointment..Healthy LifestyleSymptoms A-ZDiseases & Conditions A-ZTests & Procedures A-ZDrugs & Supplements A-ZAppointmentsPatient & Visitor GuideBilling & InsurancePatient Online ServicesDepartments & CentersMeet the StaffFind a directory of doctors and departments We'll share your response with our medical review team, who will update any incorrect information in the article. Retrieved 21 January 2013. ^ a b "Biogen Idec's TECFIDERA™ (Dimethyl Fumarate) Approved in US as a First-Line Oral Treatment for Multiple Sclerosis" (Press release).
PMID16945427. ^ Gronseth GS, Ashman EJ (May 2000). "Practice parameter: the usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis (an evidence-based review): Report of National MS Society. Olek MJ. http://www.uptodate.com/home.
Neurology. 57 (10): 1891–3. PMID8780061. ^ Nakahara J, Maeda M, Aiso S, Suzuki N (February 2012). "Current concepts in multiple sclerosis: autoimmunity versus oligodendrogliopathy.". doi:10.1016/j.clineuro.2004.02.004. https://en.wikipedia.org/wiki/Multiple_sclerosis Special Issue: 2016 Elections This is a Call to Action The Dream Will Never Die New Feminist in Office: Kamala Harris New Feminist in Office: Stephanie Murphy From the Ms.
Race. Annals of the New York Academy of Sciences. 1247: 117–37. PMID22258169. ^ "NDA 204063 - FDA Approved Labeling Text" (PDF). Accessed April 4, 2014.
- PMID15859525. ^ Steultjens EM, Dekker J, Bouter LM, Cardol M, Van de Nes JC, Van den Ende CH (2003).
- Occup Ther Int. 16 (1): 57–70.
- Biogen Idec Press Release. 14 November 2013. ^ Manouchehrinia A, Constantinescu CS (October 2012). "Cost-effectiveness of disease-modifying therapies in multiple sclerosis".
- Different symptoms can manifest themselves during relapses or attacks.
- It isn't clear why MS develops in some people and not others.
- This has led to the theory that uric acid is protective, although its exact importance remains unknown. Pathophysiology Main article: Pathophysiology of multiple sclerosis Multiple sclerosis Nerve axon with myelin sheath
- Further, if you are having an attack, your doctor may want to switch your immunosuppressive medication as this could be considered a breakthrough event.- The Healthline Medical Team 1 Article Resources
PMID19932200. ^ a b c Clanet M (June 2008). "Jean-Martin Charcot. 1825 to 1893" (PDF). http://mymsaa.org/ms-information/overview/ Take a deeper look into the symptoms of MS and the tools used to make the diagnosis... The Immune System and MS The information given in this section talks about the events that lead up to the damage and symptoms of MS. What Is Multiple Sclerosis?
doi:10.1007/s100720170011. pp.54–57. We are unable to collect your feedback at this time. It often comes on in the afternoon and causes weak muscles, slowed thinking, or sleepiness.
doi:10.1002/14651858.CD002127.pub3. Seminars in Neurology. 2013;33:5. doi:10.1016/S0140-6736(08)61620-7. Is MS Hereditary?
Current Topics in Microbiology and Immunology. 318: 1–17. doi:10.1007/s11910-012-0291-6. doi:10.1016/S1474-4422(11)70228-9.
White people, particularly those of Northern European descent, are at highest risk of developing MS.
From the age of 16 until her death at 53, she had intermittent pain, weakness of the legs, and vision loss—symptoms typical of MS. Both cases have led to the proposal The Cochrane database of systematic reviews (5): CD004678. PMID21290636. Common sites of numbness include the face, arms, legs, and fingers.
PMID14747002. ^ Skene, Nathan G.; Grant, Seth G. PMID16804331. ^ Heesen C, Mohr DC, Huitinga I, Bergh FT, Gaab J, Otte C, Gold SM (March 2007). "Stress regulation in multiple sclerosis: current issues and concepts". History of MS This section discusses the history of how and when the disease was discovered and treatments developed. Usually the symptoms get better, but then come back.
Biogen Idec. 27 March 2013. Sign up for our newsletter Thank you!